Attila B.
- Country
- Hungary
- Department
- HU10006: Reumatológiai és Fizioterápiás Osztály
Research Overview
- Phase II Randomized Study to Evaluate the Efficacy and Safety of AZD1163 in Participants with Moderately-to-Severely Active Rheumatoid Arthritis
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
- Efficacy and Safety of Sarilumab Dose Levels with a 52‑Week Prednisone Taper in Adults with Early Polymyalgia Rheumatica: Randomized Double‑Blind Placebo‑Controlled Trial
Data & Insights
Has run more than one trial at 252 of 407 partner sites.
Specializations
Inflammatory Arthritis
The investigator demonstrates significant expertise in treating psoriatic arthritis, conducting multiple clinical evaluations of novel therapeutic approaches for both biologic-naïve and biologic-experienced patients.
- Biologic Therapy Assessment
- Treatment-Resistant Cases
- Novel Therapeutic Agents
Their work encompasses various treatment modalities including guselkumab, risankizumab, and bimekizumab interventions.
Autoimmune Conditions
The investigator specializes in treating complex autoimmune disorders, with particular focus on Sjögren's syndrome and systemic lupus erythematosus. Their research includes evaluation of innovative biological treatments.
- Long-term Disease Management
- Autoimmune Disease Interventions
- Biological Treatment Safety
Their expertise extends to investigating drug delivery systems and treatment efficacy in autoimmune conditions.
Inflammatory Vascular Disorders
The investigator has dedicated research focus on inflammatory vascular conditions, particularly giant cell arteritis and polymyalgia rheumatica, investigating targeted therapeutic approaches.
- Glucocorticoid Management
- Remission Maintenance
- Long-term Safety Monitoring
Their work includes evaluation of combination therapies and steroid-sparing treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
